Clinical Trial Update: Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing flumatinib versus imatinib in combination with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Flumatinib (flumatinib)
• Imatinib (imatinib)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Leukemia | Phase 4 | Status: TERMINATED